Thumbnail Image
Publication

Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial

Chan, W. Y.
; 
Counsell, N.
; 
de Tute, R.
; 
De-Silva, D.
; 
Phillips, Elizabeth H
; 
Cavenagh, J.
; 
Adedayo, T.
; 
Braganca, N.
; 
Roddie, C.
; 
Streetly, M.
... show 10 more
Citations
Altmetric:
Abstract
Authors
Chan, W. Y.
Counsell, N.
de Tute, R.
De-Silva, D.
Phillips, Elizabeth H
Cavenagh, J.
Adedayo, T.
Braganca, N.
Roddie, C.
Streetly, M.
Schey, S.
Koh, M. B. C.
Crowe, J.
Morris, T. C.
Cook, G.
Clifton-Hadley, L.
Rabin, N.
Owen, R. G.
Popat, R.
Yong, K. L.
Affiliation
University College London Hospitals NHS Foundation Trust, London, UK
Description
Date
2021
Publisher
Collections
All Paterson Institute for Cancer Research
Show all metadata
Files
Thumbnail Image
From UNPAYWALL
Adobe PDF, 306.24 KB
Keywords
Type
Other
Citation
Chan WY, Counsell N, Tute R, De?Silva D, Phillips EH, Cavenagh J, et al. Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial. British Journal of Haematology. Wiley; 2021.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/624743
Embedded videos